Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2018 (2018), Article ID 1864307, 9 pages
https://doi.org/10.1155/2018/1864307
Research Article

Exenatide Delays the Progression of Nonalcoholic Fatty Liver Disease in C57BL/6 Mice, Which May Involve Inhibition of the NLRP3 Inflammasome through the Mitophagy Pathway

Department of Endocrinology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China

Correspondence should be addressed to Hong-Yu Kuang; moc.361@reimnefienydy

Received 7 September 2017; Revised 30 January 2018; Accepted 8 February 2018; Published 15 April 2018

Academic Editor: Niccola Funel

Copyright © 2018 Ning Shao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Ning Shao, Xin-Yang Yu, Xue-Fei Ma, Wen-Jian Lin, Ming Hao, and Hong-Yu Kuang, “Exenatide Delays the Progression of Nonalcoholic Fatty Liver Disease in C57BL/6 Mice, Which May Involve Inhibition of the NLRP3 Inflammasome through the Mitophagy Pathway,” Gastroenterology Research and Practice, vol. 2018, Article ID 1864307, 9 pages, 2018. doi:10.1155/2018/1864307